4.7 Review

Glycosylation Alterations in Cancer Cells, Prognostic Value of Glycan Biomarkers and Their Potential as Novel Therapeutic Targets in Breast Cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Therapeutic vaccines for breast cancer: Has the time finally come?

Chiara Corti et al.

Summary: The use of the immune system as a weapon against cancer, particularly through immune checkpoint inhibitors (ICIs), has revolutionized cancer treatment. However, the effectiveness of ICIs in treating breast cancer (BC) is limited, except for certain subsets of triple-negative BCs. The tumor microenvironment (TME), which is immune-suppressive in BC, plays a crucial role in the poor response to immunotherapy. Cancer vaccines (CVs), as active immunotherapy, have regained attention due to technological advancements and the COVID-19 pandemic, with a focus on neoantigens as preferred targets. Lipid nanoparticles have also shown promise as effective delivery vehicles for CVs. Past clinical trials mainly focused on metastatic disease, where the TME is more likely compromised by inhibitory mechanisms. Promising strategies include using CVs as monotherapy in premalignant or adjuvant settings, and combining CVs with ICIs in late-stage disease. This review provides a comprehensive overview of the current landscape of breast cancer vaccines.

EUROPEAN JOURNAL OF CANCER (2022)

Article Multidisciplinary Sciences

D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1

Ruonan Zhang et al.

Summary: D-mannose facilitates triple-negative breast cancer treatment by degrading PD-L1 and enhances the efficacy of radiotherapy.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Immunology

O-Acetyl-GD2 as a Therapeutic Target for Breast Cancer Stem Cells

Jing-Yan Cheng et al.

Summary: OAcGD2 is a novel marker for breast cancer stem cells, and treatment with anti-OAcGD2 mAb8B6 can suppress tumor growth and reduce cancer metastasis and recurrence.

FRONTIERS IN IMMUNOLOGY (2022)

Review Biochemistry & Molecular Biology

Glycosphingolipids in human embryonic stem cells and breast cancer stem cells, and potential cancer therapy strategies based on their structures and functions

Yuh-Jin Liang

Summary: This study systematically surveyed the expression profiles of glycosphingolipids in human embryonic stem cells and their differentiated cells, and found that the switching of core structure in glycosphingolipids was associated with cell differentiation and characteristics of breast cancer stem cells.

GLYCOCONJUGATE JOURNAL (2022)

Article Biochemistry & Molecular Biology

New and Emerging Targeted Therapies for Advanced Breast Cancer

Kristie H. Lau et al.

Summary: This article discusses the incidence and classification of breast cancer in the United States, and explores the main treatment methods, including surgery, radiation therapy, chemotherapy, endocrine therapy, and targeted therapy. It also highlights the research focus on triple-negative breast cancer treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Functional Role of Glycosphingolipids in Cancer

Changping Zheng et al.

Summary: Glycosphingolipids (GSLs) are important components on animal cell membranes, with specific types expressed more in tumors than in normal tissues. Abnormal GSLs patterns and signaling in tumor cells play a major role in tumor development, and tumor-associated GSL antigens have been used in antitumor vaccines. It is clear that GSLs play a crucial role in tumor progression and are a promising target for cancer treatment.

CURRENT MEDICINAL CHEMISTRY (2021)

Review Biochemistry & Molecular Biology

Altered glycosylation in cancer: A promising target for biomarkers and therapeutics

Divya Thomas et al.

Summary: Glycosylation is a crucial post-translational modification that plays a significant role in health and diseases. Aberrantly glycosylated proteins have been recognized as modulators of cancer cell phenotype, highlighting the potential of glycans as novel clinical biomarkers. The roles of glycans in tumor progression emphasize their promising target for cancer therapy.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

Review Biochemistry & Molecular Biology

The application of CA72-4 in the diagnosis, prognosis, and treatment of gastric cancer

Yitian Xu et al.

Summary: CA72-4, as a tumor marker, plays an important role in the diagnosis, prognosis, and treatment of GC, especially in the Chinese population. By combining with other biomarkers and improving detection techniques, the sensitivity and specificity of CA72-4 can be enhanced. Furthermore, CA72-4 can evaluate therapeutic effectiveness and enhance drug efficacy.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2021)

Review Biochemistry & Molecular Biology

FUT8 Alpha-(1,6)-Fucosyltransferase in Cancer

Kayla Bastian et al.

Summary: Aberrant glycosylation, particularly altered core fucosylation driven by FUT8, is a universal feature of cancer cells impacting tumor progression. Upregulated FUT8 plays critical roles in immune evasion and cancer development, outlining potential opportunities for future therapeutics targeting FUT8.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Chemistry, Medicinal

Sialyltransferase Inhibitors Suppress Breast Cancer Metastasis

Chih-Wei Fu et al.

Summary: Our study reports the synthesis and evaluation of a series of cell-permeable and N- versus O-selective sialyltransferase inhibitors. Among them, FCW34 and FCW66 were shown to effectively inhibit cell migration, with FCW34 also demonstrating inhibitory effects on tumor growth, angiogenesis, and cancer cell metastasis.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Review Biotechnology & Applied Microbiology

The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans

Benjamin A. H. Smith et al.

Summary: Carbohydrates, specifically glycans, decorate every cell in the human body and most secreted proteins. Advances in genomics, glycoproteomics, and tools from chemical biology have made glycobiology more understandable and tractable. Dysregulated glycosylation plays a major role in disease processes, sparking research targeting glycans for therapeutic benefit and leading to a boom in drug development in the field.

NATURE REVIEWS DRUG DISCOVERY (2021)

Article Oncology

ALG3 contributes to stemness and radioresistance through regulating glycosylation of TGF-β receptor II in breast cancer

Xiaoqing Sun et al.

Summary: ALG3 overexpression in breast cancer patients leads to enhanced radioresistance and cancer stemness. Additionally, ALG3 influences early recurrence prognosis in breast cancer patients by regulating glycosylation of TGFBR2. Radiation remains an effective mainstay therapy for patients with low ALG3 levels to prevent early recurrence in breast cancer.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Medicine, Research & Experimental

Clinical importance of high-mannose ,fucosylated, and complex N-glycans in breast cancer metastasis

Klara Scupakova et al.

Summary: The study reveals that N-glycosylation of breast cancer cells changes in a site-specific manner during metastasis, highlighting the clinical significance of high-mannose, fucosylated, and complex N-glycans as potential diagnostic markers and therapeutic targets in metastatic breast cancer.

JCI INSIGHT (2021)

Review Cell Biology

Glycosylation of Immune Receptors in Cancer

Ruoxuan Sun et al.

Summary: Evasion of host immune surveillance is a hallmark of cancer, and immune checkpoint therapy aims to eliminate cancer progression by reprogramming the antitumor immune response. Understanding the impact of protein glycosylation on immune function will drive the rational development of future cancer diagnostics and therapeutic strategies.
Review Biochemistry & Molecular Biology

Integrative Multi-Omics Approaches in Cancer Research: From Biological Networks to Clinical Subtypes

Yong Jin Heo et al.

Summary: Multi-omics approaches integrate multiple omics datasets to better understand cancer, classify cancers into subtypes, improve survival prediction and therapeutic outcome, and understand key pathophysiological processes. Emerging omics algorithms provide unprecedented opportunities in cancer research, leading to advancements in patient subtyping and drug development. Large-scale multi-omics studies have significant implications for improving cancer treatment and patient outcomes.

MOLECULES AND CELLS (2021)

Article Oncology

sLex expression in invasive micropapillary breast carcinoma is associated with poor prognosis and can be combined with MUC1/EMA as a supplementary diagnostic indicator

Yawen Song et al.

Summary: The study evaluated the expression of MUC1/EMA and sLe(x) in IMPC and IDC-NOS patients, finding a higher expression in IMPC cells and a correlation with nodal metastasis. The high cytomembrane expression of sLe(x) in IMPC indicated poor prognosis. Additionally, IMPC cells showed different expression patterns compared to IDC-NOS cells.

CANCER BIOLOGY & MEDICINE (2021)

Article Biochemistry & Molecular Biology

Synthesis and immunological evaluation of N-acyl modified Globo H derivatives as anticancer vaccine candidates

Canjia Zhai et al.

Summary: Several modified Globo H analogues were prepared and conjugated with carrier protein to form glycoconjugates as anticancer vaccine candidates. Immunological studies demonstrated the potential of these synthetic glycoconjugates as anticancer vaccine candidates.

RSC MEDICINAL CHEMISTRY (2021)

Review Oncology

Insights into the role of sialylation in cancer progression and metastasis

Christopher Dobie et al.

Summary: The upregulation of sialyltransferases and hypersialylation on tumour cell surfaces are established hallmarks of various cancers, promoting tumour metastasis. Targeting sialylation as a potential anti-metastatic cancer treatment strategy shows promise in inhibiting tumour growth and spread.

BRITISH JOURNAL OF CANCER (2021)

Article Biochemistry & Molecular Biology

Saccharide analog, 2-deoxy-d-glucose enhances 4-1BB-mediated antitumor immunity via PD-L1 deglycosylation

Bareun Kim et al.

MOLECULAR CARCINOGENESIS (2020)

Article Multidisciplinary Sciences

Breast cancer diagnosis by analysis of serum N-glycans using MALDI-TOF mass spectroscopy

Sae Byul Lee et al.

PLOS ONE (2020)

Review Oncology

Role of Immunotherapy in Triple-Negative Breast Cancer

Tanya E. Keenan et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)

Review Biochemistry & Molecular Biology

Targeting glycosphingolipids for cancer immunotherapy

John Yu et al.

FEBS LETTERS (2020)

Article Biochemistry & Molecular Biology

Human Natural Antibodies Recognizing Glycan Galβ1-3GlcNAc (Le©)

Kira Dobrochaeva et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Cell Biology

Global view of human protein glycosylation pathways and functions

Katrine T. Schjoldager et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)

Review Oncology

New era of research on cancer-associated glycosphingolipids

Koichi Furukawa et al.

CANCER SCIENCE (2019)

Article Biochemical Research Methods

Comprehensive N-Glycome Profiling of Cells and Tissues for Breast Cancer Diagnosis

Qinying Li et al.

JOURNAL OF PROTEOME RESEARCH (2019)

Article Multidisciplinary Sciences

Signaling pathway of globo-series glycosphingolipids and β1,3-galactosyltransferase V (β3GalT5) in breast cancer

Po-Kai Chuang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Oncology

Elevated serum levels of sialyl Lewis X (sLeX) and inflammatory mediators in patients with breast cancer

Evan N. Cohen et al.

BREAST CANCER RESEARCH AND TREATMENT (2019)

Review Biochemical Research Methods

Glycosylation and its implications in breast cancer

Danielle A. Scott et al.

EXPERT REVIEW OF PROTEOMICS (2019)

Review Oncology

The Role of Glypican-3 in Regulating Wnt, YAP, and Hedgehog in Liver Cancer

Aarti Kolluri et al.

FRONTIERS IN ONCOLOGY (2019)

Article Oncology

Innovative approaches for cancer treatment: current perspectives and new challenges

Carlotta Pucci et al.

ECANCERMEDICALSCIENCE (2019)

Article Cell Biology

Fucosyltransferase 1 and 2 play pivotal roles in breast cancer cells

Tai-Yu Lai et al.

CELL DEATH DISCOVERY (2019)

Article Biochemical Research Methods

Genome, transcriptome and proteome: the rise of omics data and their integration in biomedical sciences

Claudia Manzoni et al.

BRIEFINGS IN BIOINFORMATICS (2018)

Review Oncology

Immunotherapy in triple-negative breast cancer

Heather Katz et al.

MEDICAL ONCOLOGY (2018)

Editorial Material Oncology

Glycans Pave the Way for Immunotherapy in Triple-Negative Breast Cancer

Mariana Salatino et al.

CANCER CELL (2018)

Article Oncology

Differences in Breast Cancer Survival by Molecular Subtypes in the United States

Nadia Howlader et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2018)

Article Biochemistry & Molecular Biology

Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1

Jong-Ho Cha et al.

MOLECULAR CELL (2018)

Review Oncology

What is the role of immunotherapy in breast cancer?

Tira J. Tan et al.

CHINESE CLINICAL ONCOLOGY (2018)

Review Biochemical Research Methods

Glycans and glycoproteins as specific biomarkers for cancer

Muchena J. Kailemia et al.

ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2017)

Review Medicine, General & Internal

Breast cancer

Nadia Harbeck et al.

LANCET (2017)

Article Oncology

Improved survival in metastatic breast cancer 1985-2016

Marie Sundquist et al.

BREAST (2017)

Review Biochemistry & Molecular Biology

Recent Advance in Tumor-associated Carbohydrate Antigens (TACAs)-based Antitumor Vaccines

Danyang Feng et al.

ACS CHEMICAL BIOLOGY (2016)

Article Biochemistry & Molecular Biology

Mechanisms of disease: The human N-glycome

Gordan Lauc et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2016)

Review Medicine, Research & Experimental

N-glycans of growth factor receptors: their role in receptor function and disease implications

Motoko Takahashi et al.

CLINICAL SCIENCE (2016)

Review Pharmacology & Pharmacy

Current Challenges in Cancer Treatment

Jon Zugazagoitia et al.

CLINICAL THERAPEUTICS (2016)

Review Pathology

Protein Glycosylation in Cancer

Sean R. Stowell et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 10 (2015)

Review Oncology

Glycosylation in cancer: mechanisms and clinical implications

Salome S. Pinho et al.

NATURE REVIEWS CANCER (2015)

Article Biochemistry & Molecular Biology

β-Galactoside α2,6-Sialyltranferase 1 Promotes Transforming Growth Factor-β-mediated Epithelial-Mesenchymal Transition

Jishun Lu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Review Cell Biology

Molecular mechanisms of epithelial-mesenchymal transition

Samy Lamouille et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)

Review Biochemistry & Molecular Biology

MUC1: a multifaceted oncoprotein with a key role in cancer progression

Sritama Nath et al.

TRENDS IN MOLECULAR MEDICINE (2014)

Article Pathology

Expression of Lewis X Is Associated With Poor Prognosis in Triple-Negative Breast Cancer

Young Wha Koh et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2013)

Review Medical Laboratory Technology

The Long Journey of Cancer Biomarkers from the Bench to the Clinic

Maria P. Pavlou et al.

CLINICAL CHEMISTRY (2013)

Article Biochemistry & Molecular Biology

TRAF4 Promotes TGF-β Receptor Signaling and Drives Breast Cancer Metastasis

Long Zhang et al.

MOLECULAR CELL (2013)

Article Biochemistry & Molecular Biology

Ragulator Is a GEF for the Rag GTPases that Signal Amino Acid Levels tomTORC1

Liron Bar-Peled et al.

Review Oncology

Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade

Leisha A. Emens

EXPERT REVIEW OF ANTICANCER THERAPY (2012)

Review Oncology

Cancer biomarkers

N. Lynn Henry et al.

MOLECULAR ONCOLOGY (2012)

Article Biochemical Research Methods

High-Mannose Glycans are Elevated during Breast Cancer Progression

Maria Lorna A. de Leoz et al.

MOLECULAR & CELLULAR PROTEOMICS (2011)

Review Oncology

Tumour-associated carbohydrate antigens in breast cancer

Aurelie Cazet et al.

BREAST CANCER RESEARCH (2010)

Article Oncology

Cell surface α2,6-sialylation affects adhesion of breast carcinoma cells

SQ Lin et al.

EXPERIMENTAL CELL RESEARCH (2002)